These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33691614)

  • 1. IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice.
    Kim KH; Hong GL; Jung DY; Karunasagara S; Jeong WI; Jung JY
    Mol Med; 2021 Mar; 27(1):25. PubMed ID: 33691614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
    Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
    J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATF4 promotes renal tubulointerstitial fibrosis by suppressing autophagy in diabetic nephropathy.
    Liang Q; Liu T; Guo T; Tao W; Chen X; Chen W; Chen L; Xiao Y
    Life Sci; 2021 Jan; 264():118686. PubMed ID: 33129879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway.
    Li A; Yi B; Han H; Yang S; Hu Z; Zheng L; Wang J; Liao Q; Zhang H
    Autophagy; 2022 Apr; 18(4):877-890. PubMed ID: 34432556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of programmed cell death in streptozotocin-induced early diabetic nephropathy.
    Wu WH; Zhang MP; Zhang F; Liu F; Hu ZX; Hu QD; Yan XY; Huang SM
    J Endocrinol Invest; 2011 Oct; 34(9):e296-301. PubMed ID: 21597317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
    Barutta F; Bellini S; Kimura S; Hase K; Corbetta B; Corbelli A; Fiordaliso F; Bruno S; Biancone L; Barreca A; Papotti MG; Hirsh E; Martini M; Gambino R; Durazzo M; Ohno H; Gruden G
    Autophagy; 2023 Feb; 19(2):505-524. PubMed ID: 35659195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy.
    Jialal I; Major AM; Devaraj S
    J Diabetes Complications; 2014; 28(6):755-61. PubMed ID: 25116192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT.
    Cho A; Jin W; Lee J; Shin N; Lee MS; Li L; Yang SH; Park KS; Yang CW; Kim DK; Oh YK; Lim CS; Lee JP
    Sci Rep; 2023 Oct; 13(1):17599. PubMed ID: 37845302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
    Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
    Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
    Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.
    Devaraj S; Tobias P; Kasinath BS; Ramsamooj R; Afify A; Jialal I
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1796-804. PubMed ID: 21617141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy.
    He J; Liu B; Du X; Wei Y; Kong D; Feng B; Guo R; Asiamah EA; Griffin MD; Hynes SO; Shen S; Liu Y; Cui H; Ma J; O'Brien T
    Stem Cell Res Ther; 2024 Mar; 15(1):66. PubMed ID: 38443965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy.
    Liu J; Li QX; Wang XJ; Zhang C; Duan YQ; Wang ZY; Zhang Y; Yu X; Li NJ; Sun JP; Yi F
    Cell Death Dis; 2016 Apr; 7(4):e2183. PubMed ID: 27054338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of low-dose TGF-β1 in early diabetic nephropathy induced by streptozotocin.
    Ma X; Ding J; Min H; Wen Y; Gao Q
    Int Immunopharmacol; 2013 Nov; 17(3):752-8. PubMed ID: 24055008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase-2 mediates diabetic renal injury.
    Morris SM; Gao T; Cooper TK; Kepka-Lenhart D; Awad AS
    Diabetes; 2011 Nov; 60(11):3015-22. PubMed ID: 21926276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
    Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
    Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phlorizin pretreatment reduces acute renal toxicity in a mouse model for diabetic nephropathy.
    Brouwers B; Pruniau VPEG; Cauwelier EJG; Schuit F; Lerut E; Ectors N; Declercq J; Creemers JWM
    J Biol Chem; 2013 Sep; 288(38):27200-27207. PubMed ID: 23940028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.